Carver Kyle
Chief Financial Officer
Carver Kyle has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 10, 2026.
On the most recent filing, Carver Kyle is listed as Chief Financial Officer at Evommune, Inc. Inside the rolling window, Carver Kyle reported 1 open-market purchase totaling $13K in EVMN and 1 open-market sale totaling $415K in EVMN. The largest disclosed transaction in the window is a sale of 18,175 EVMN shares on May 28, 2026, worth $415K.
Companies traded
Other insiders at EVMN
Insider Buying
$13K
reported purchases (SEC code P)
Insider Selling
$415K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Carver Kyle made?
Carver Kyle has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Carver Kyle trade?
Carver Kyle has filed SEC Form 4 disclosures for 1 company, including EVMN.
When was Carver Kyle's most recent SEC Form 4 filing?
Carver Kyle's most recent SEC Form 4 filing on Tracefour is dated Jul 10, 2026.
What is Carver Kyle's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Carver Kyle is listed as Chief Financial Officer.
What is Carver Kyle's total buy and sell value in the current window?
Inside the rolling retention window, Carver Kyle bought $13K and sold $415K based on SEC Form 4 filings.
What was Carver Kyle's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,175 EVMN shares on 2026-05-28, worth $415K, per SEC Form 4 filings.